Logo

kidney disease

Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests

Renalytix said it will receive about $1 million in consortium funding to oversee commercial translation activities around the tests.

Renalytix Posts $2.9M in Revenue for Fiscal 2022

The kidney disease-focused in vitro diagnostics firm nearly doubled the previous year's revenue and posted a net loss of $45.3 million in the year ending June 30.

Kidney Disease Targets Uncovered in Integrated Omics Analysis

Using genetic, epigenetic, expression, and other data, researchers narrowed in on genes, pathways, and cell types involved in kidney disease.

Use of Community Resources to Inform Black Patients of Genetic Test Results Improves Outcomes, Study Finds
Premium

The study looked at Black patients with the APOL1 genotype, a signifier of increased risk of kidney failure.

RenalytixAI, Wake Forest, Atrium Health Partner on Kidney Health Initiative

RenalytixAI will offer its KidneyIntelX platform through Atrium Health's electronic health record system at 37 hospitals across the Carolinas and Georgia.

Apr 22, 2021

Renalytix AI Lands US Government Contract for Kidney Disease Test

Mar 19, 2021

NephroSant Readies Launch of Kidney Transplant Rejection Assay
Premium

Mar 17, 2021

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Mar 16, 2021

NephroSant Raises $16M in Series A Funding Round

Feb 24, 2021

RenalytixAI Inks Deal to Introduce Kidney Function Testing Platform at University of Utah Health

Jan 22, 2021

Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease
Premium

Jan 19, 2021

Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores

Dec 2, 2020

Bio-Techne, Regulus Therapeutics to Develop Assays for Kidney Disease Treatment

Nov 3, 2020

Natera Aims to Improve Prospera Kidney Test After Findings Reveal Cell-Free DNA Changes in Infection
Premium

Aug 21, 2020

RenalytixAI, AstraZeneca Ink Agreement to Enhance Chronic Disease Patient Outcomes

Jun 30, 2020

RenalytixAI Inks Kidney Disease Dx Deals With University of Michigan, Global Pharmaceutical Firm

Jun 12, 2020

RenalytixAI Receives Approval From New York State to Offer Kidney Test

Apr 28, 2020

RenalytixAI, Mount Sinai Launch Study to Predict COVID-19 Kidney Complications
Premium

Mar 18, 2020

Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay
Premium

Mar 17, 2020

Viracor Eurofins, National Kidney Registry Partner to Provide SARS-CoV-2 Testing

Feb 18, 2020

Natera Countersues CareDx for False Advertising

Jan 21, 2020

Urinary Metabolite GWAS Leads to Risk Variants, Potential Markers of Kidney Disease

Jan 8, 2020

Magistrate Judge Recommends Partial Rejection of Natera Motion to Dismiss CareDx False Advertising Lawsuit

Dec 19, 2019

Natera Obtains Final Medicare Local Coverage Determination for Kidney Transplant Test From Palmetto

Dec 6, 2019

Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.